Clovis Oncology
CLVS
#10870
Rank
ยฃ8.99 M
Marketcap
ยฃ0.06207
Share price
0.00%
Change (1 day)
-95.09%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -ยฃ0.18 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are ยฃ0.13 Billion. In 2021 the company made an earning of -ยฃ0.18 Billion, an increase over its 2020 earnings that were of -ยฃ0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -ยฃ0.18 Billion-2.12%
2021 -ยฃ0.18 Billion-32.64%
2020 -ยฃ0.27 Billion-9.06%
2019 -ยฃ0.3 Billion7.49%
2018 -ยฃ0.28 Billion4.42%
2017 -ยฃ0.26 Billion-8.83%
2016 -ยฃ0.29 Billion-0.4%
2015 -ยฃ0.29 Billion140.82%
2014 -ยฃ0.12 Billion86.64%
2013 -ยฃ63.54 Million19.53%
2012 -ยฃ53.16 Million
2010 -ยฃ20.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.31 B-8,711.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ5.32 B-3,305.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ9.79 B-5,994.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ26.57 B-16,092.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ11.53 B-7,040.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
ยฃ33.37 M-120.08%๐Ÿ‡บ๐Ÿ‡ธ USA